Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAIKO: ASA Injection for Knee Osteoarthritis
NCT06704893Phase 3Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Oct 2024
- Primary completion
- Dec 2027
- Modality
- Implantable Devices, Implantable Hydrogels
- Countries
- 1
01
Overview
A Phase 3 trial of AMNIOGEN in knee osteoarthritis (OA), sponsored by Chang Gung Memorial Hospital. Started Oct 2024; status: recruiting.
02
Drugs
AMNIOGEN
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06704893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06704893.